Personalbio is a biotechnology startup founded in 2011, which specializes in advanced gene sequencing and genetic testing, aiming to empower health management and enhance quality of life. The company offers personalized gene examination packages, leveraging biotechnological services to enable individuals to take proactive measures in managing their health. Its recent milestone includes securing a noteworthy $3.14M Series A investment on 02 May 2018, with funding from 南京扬子国资投资集团有限责任公司. With a focus on the intersection of biotechnology and healthcare, Personalbio is positioned to make impactful strides in personalized health solutions.
No recent news or press coverage available for Personalbio.